wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q47109075-23D5ECC3-E6F9-432B-AB4D-AA99A30497C0
Q47109075-23D5ECC3-E6F9-432B-AB4D-AA99A30497C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47109075-23D5ECC3-E6F9-432B-AB4D-AA99A30497C0
Multicenter phase II study of apatinib treatment for metastatic gastric cancer after failure of second-line chemotherapy.
P2860
Q47109075-23D5ECC3-E6F9-432B-AB4D-AA99A30497C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47109075-23D5ECC3-E6F9-432B-AB4D-AA99A30497C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ee1b548a176020718f70200c6c07cfa3497ebf2
P2860
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo.